We are studying whether Vinblastine can effectively treat children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma. The goal is to see if it can cure at least 75% of these patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
ALK-positive anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma that primarily affects lymphatic tissue and is characterized by the presence of the ALK gene mutation. It can cause symptoms such as swollen lymph nodes, fever, weight loss, and night sweats.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
